Intralesional nivolumab appeared effective for treating precancerous oral lesions in a phase 1, open-label, dose-escalation trial.

The injection of immunotherapy directly into precancerous oral lesions may reduce risk for progression to cancer and help ...

Injecting nivolumab (Opdivo) directly into precancerous oral lesions led to reduction in lesion size and allowed some ...

Oral lesions can range from harmless irritations to early signs of cancer, making timely detection critical. Dentists play a pivotal role by performing thorough visual and tactile exams, recognizing ...

Direct injection of a low dose of the immune checkpoint inhibitor nivolumab into precancerous oral lesions significantly reduced lesion size and risk of cancer progression, sparing most patients from ...

Detection, evaluation, and management of oral lesions are critical responsibilities for oral healthcare providers. Although most oral lesions are benign, they can represent chronic mucosal disorders ...

Oral pyogenic granuloma is a benign but fast-growing vascular lesion that often appears on the gums and bleeds easily. It can be triggered by local irritation, hormonal changes, or certain medications ...

The connection between HPV and oral cancer is becoming clearer. Some population types and risk factors have become closely linked to HPV-associated OSCC. The relationship between HPV-associated OSCC ...

SAN FRANCISCO - While commercially available optical tools can help clinicians identify premalignant lesions in the oral cavity, the prevalence of confounding lesions increases the rate of false ...

Intralesional nivolumab seems effective for reducing the size of precancerous oral lesions, according to a study presented at the annual meeting of the American Association for Cancer Research, held ...

Several case histories have been reported in the literature, with the prevalence of HPV DNA detection in cancers ranging from 0% to 100%, depending on the population, combination of topographies, type ...